Now on ScienceBlogs: Rhodes Secretary: Wall Street Megabonuses Draining Our Young Talent
Commentary on human genetics and evolution, direct-to-consumer genetic testing, and the personal genomics industry.
Daniel MacArthur
I write about the genetic and evolutionary basis of human variation, and the companies trying to sell you information about your genome.
Subscribe via RSS.
Follow me on Twitter.
September 29, 2009
Category: genetic ancestry testing
The UK Border Agency has sparked outrage from scientists and refugee advocates by proposing the use of genetic and isotope tests for the determination of geographical ancestry in making decisions on refugee status.
Posted by Daniel MacArthur at 8:00 AM • 12 Comments •
September 16, 2009
In the final entry in a three-part series of guest posts, lawyers Daniel Vorhaus and Lawrence Moore spell out the implications for personal genomics customers if their data provider goes bankrupt.
Posted by Daniel MacArthur at 9:00 AM • 6 Comments •
Category: next-generation sequencing
Two interviews in Bio-IT World shed light on the rapidly evolving world of new sequencing technology, and the informatic challenges created by that evolution.
Posted by Daniel MacArthur at 7:00 AM • 4 Comments •
September 15, 2009
Category: direct-to-consumer genetic testing
Personal genomics company 23andMe is considering offering discounted genome scans to clinicians to help them to make sense of the complexities of modern common disease genetics.
Posted by Daniel MacArthur at 10:00 AM • 5 Comments •
Category: commercial genetic testing
In part 2 of a three-part series of guest post, lawyers Daniel Vorhaus and Lawrence Moore analyse the legal repercussions of a personal genomics company going bankrupt - what will happen to your data?
Posted by Daniel MacArthur at 9:00 AM • 2 Comments •
September 14, 2009
Category: direct-to-consumer genetic testing
In the first of three guest posts, lawyers Daniel Vorhaus and Lawrence Moore explore the intriguing question of what happens to customers' genetic data when a personal genomics company goes bankrupt.
Posted by Daniel MacArthur at 9:00 AM • 8 Comments •
September 9, 2009
My esteemed blogging colleague Ginny Hughes will be presenting at next week's Cold Spring Harbor Personal Genomes meeting (which I, sadly, will not be attending) on genetic testing for psychiatric diseases. As part of preparing for this she'd like to...
Posted by Daniel MacArthur at 8:45 AM • 2 Comments •
September 3, 2009
Category: direct-to-consumer genetic testing
Germany's regressive new laws against direct-to-consumer genetic testing are transparently designed to avoid memories of eugenics and non-consensual medical experimentation - but restricting citizens from being able to access their own genetic information is not the right way to shake the horrors of the past.
Posted by Daniel MacArthur at 5:15 AM • 19 Comments •
September 2, 2009
Category: direct-to-consumer genetic testing
The New York Times has an article pushing the possible dangers of customers peering into their own genome without supervision - but what supervision should customers look for, given that most doctors know less about modern genetics than the customers themselves?
Posted by Daniel MacArthur at 2:30 PM • 30 Comments •
September 1, 2009
Category: next-generation sequencing
Sequencing company Illumina has delivered its first commercial personal whole genome sequence to entrepreneur Hermann Hauser.
Posted by Daniel MacArthur at 5:30 AM • 6 Comments •
PZ Myers 11.19.2009
James Hrynyshyn 11.20.2009
Ed Brayton 11.21.2009
PZ Myers 11.14.2009
Greg Laden 11.21.2009
